Apr 2 |
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|
Apr 2 |
Aditxt signs agreement to acquire Appili Therapeutics
|
Apr 2 |
Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)
|
Mar 27 |
Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023
|
Mar 7 |
For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy
|
Feb 1 |
Evofem Biosciences achieves 2023 prelim net product sales of $18.1M to $18.3M
|
Feb 1 |
Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023
|
Jan 30 |
Aditxt buys Brain Scientific's portfolio of EEG brain monitoring technologies and devices
|
Jan 30 |
Aditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap™ and NeuroEEG™ for Telehealth and Tele-neurology Applications
|
Jan 18 |
Aditxt files to sell 3.79M shares for holders
|